Terms: = Myeloproliferative Neoplasm AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Diagnosis
2187 results:
1. Late presentation of chronic myeloid leukaemia patients in a low-income country: the prognostic implications and impact on treatment outcome.
Nelson EA; Ahmed IO; Bolarinwa RA; Adeagbo BA; Adegbola AJ; Salawu L; Bolaji OO; Durosinmi MA
BMC Res Notes; 2024 Sep; 17(1):245. PubMed ID: 39227850
[TBL] [Abstract] [Full Text] [Related]
2. Gene Variants in Components of the microRNA Processing Pathway in Chronic Myeloid Leukemia.
Chavaro-Francisco G; Hernández-Zavala A; Bravo-Cidro CE; Rios-Rodriguez S; Muciño-Sánchez M; López-López M; Castro-Martínez XH; Olarte-Carrillo I; Garcia-Laguna A; Barranco-Lampón G; De la Cruz-Rosas A; Martínez-Tovar A; Córdova EJ
Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202414
[TBL] [Abstract] [Full Text] [Related]
3. Application of artificial intelligence in chronic myeloid leukemia (cml) disease prediction and management: a scoping review.
Ram M; Afrash MR; Moulaei K; Parvin M; Esmaeeli E; Karbasi Z; Heydari S; Sabahi A
BMC Cancer; 2024 Aug; 24(1):1026. PubMed ID: 39164653
[TBL] [Abstract] [Full Text] [Related]
4. Cytogenetics and genomics in cml and other myeloproliferative neoplasms.
Kreipe HH; Schlegelberger B
Best Pract Res Clin Haematol; 2024 Jun; 37(2):101552. PubMed ID: 39098796
[TBL] [Abstract] [Full Text] [Related]
5. Superior detection of low-allele burden Janus kinase 2 V617F mutation and monitoring clonal evolution in myeloproliferative neoplasms using chip-based digital PCR.
Lu Y; Lin L; Lin J; Wu B; Cai G; Wang X; Ma X
Ann Hematol; 2024 Sep; 103(9):3553-3562. PubMed ID: 39043913
[TBL] [Abstract] [Full Text] [Related]
6. The therapeutic and biomarker significance of ferroptosis in chronic myeloid leukemia.
Zhong F; Zhang X; Wang Z; Li X; Huang B; Kong G; Wang X
Front Immunol; 2024; 15():1402669. PubMed ID: 39026664
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Characteristics and diagnosis of Nonaccelerating MDS/MPN-U Patient with Granulocyte Dysplasia.
Jin N; Li S
Clin Lab; 2024 Jul; 70(7):. PubMed ID: 38965949
[TBL] [Abstract] [Full Text] [Related]
8. cml in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study.
Rozental A; Halperin E; Leibovitch C; Barzili M; Michowitz MK; Duek A; Rozovski U; Extermann M; Raanani P; Shacham-Abulafia A
Ann Hematol; 2024 Sep; 103(9):3585-3594. PubMed ID: 38862792
[TBL] [Abstract] [Full Text] [Related]
9. Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
Heim D; Baldomero H; Medinger M; Masouridi-Levrat S; Schanz U; Nair G; Güngör T; Halter J; Passweg JR; Chalandon Y;
Swiss Med Wkly; 2024 May; 154():3754. PubMed ID: 38749067
[TBL] [Abstract] [Full Text] [Related]
10. Analytical validation of the DropXpert S6 system for diagnosis of chronic myelocytic leukemia.
Wei W; Li S; Zhang Y; Deng S; He Q; Zhao X; Xu Y; Yu L; Ye J; Zhao W; Jiang Z
Lab Chip; 2024 Jun; 24(12):3080-3092. PubMed ID: 38747247
[TBL] [Abstract] [Full Text] [Related]
11. [Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].
Zhang XS; Liu BC; Du X; Zhang YL; Xu N; Liu XL; Li WM; Lin H; Liang R; Chen CY; Huang J; Yang YF; Zhu HL; Pan L; Wang XD; Li GH; Liu ZG; Zhang YQ; Liu ZF; Hu JD; Liu CS; Li F; Yang W; Meng L; Han YQ; Lin LE; Zhao ZY; Tu CQ; Zheng CF; Bai YL; Zhou ZP; Chen SN; Qiu HY; Yang LJ; Sun XL; Sun H; Zhou L; Liu ZL; Wang DY; Guo JX; Pang LP; Zeng QS; Suo XH; Zhang WH; Zheng YJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):215-224. PubMed ID: 38716592
[No Abstract] [Full Text] [Related]
12. CRKL but not CRKII contributes to hemin-induced erythroid differentiation of cml.
Guo C; Lv X; Zhang Q; Yi L; Ren Y; Li Z; Yan J; Zheng S; Sun MZ; Liu S
J Cell Mol Med; 2024 May; 28(9):e18308. PubMed ID: 38683131
[TBL] [Abstract] [Full Text] [Related]
13. Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco.
Benchikh S; Charlène SSG; Bousfiha A; Razoki L; Aboulfaraj J; Zarouf L; Hamouchi AE; Malki A; Nassereddine S
Ann Hematol; 2024 Aug; 103(8):2765-2774. PubMed ID: 38653807
[TBL] [Abstract] [Full Text] [Related]
14. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
Szuber N; Orazi A; Tefferi A
Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693
[TBL] [Abstract] [Full Text] [Related]
15. Clinical applications of abnormal DNA methylation in chronic myeloid leukemia.
Zhou L; Yin X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 49(1):122-127. PubMed ID: 38615173
[TBL] [Abstract] [Full Text] [Related]
16. Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells.
Tezcanli Kaymaz B; Gumus N; Celik B; Alcitepe İ; Biray Avci C; Aktan C
J Interferon Cytokine Res; 2024 Apr; 44(4):178-189. PubMed ID: 38579140
[TBL] [Abstract] [Full Text] [Related]
17. [Discontinuation of tyrosine kinase inhibitors before epiphyseal closure leading to improved short stature in pediatric chronic myelogenous leukemia].
Fukui W; Ogura T; Azumi S; Ogata H; Kawaguchi K; Takachi T; Horikoshi Y; Uematsu A; Shimada H; Watanabe K
Rinsho Ketsueki; 2024; 65(3):175-179. PubMed ID: 38569862
[TBL] [Abstract] [Full Text] [Related]
18. Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.
Aguirre LE; Jain A; Ball S; Ali NA; Volpe VO; Tinsley-Vance S; Sallman D; Sweet K; Lancet J; Padron E; Yun S; Kuykendall A; Komrokji R
Clin Lymphoma Myeloma Leuk; 2024 Jul; 24(7):459-467. PubMed ID: 38548563
[TBL] [Abstract] [Full Text] [Related]
19. The Screening of microRNAs in Chronic Myeloid Leukemia: A Clinical Evaluation.
Wosniaki DK; Marin AM; Oliveira RN; Koerich GM; Munhoz EC; Farias JSH; Beltrame MP; Zanette DL; Aoki MN
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542337
[TBL] [Abstract] [Full Text] [Related]
20. Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: influence of demographic, pharmacological, and genetic factors in the German cml-PAED cohort.
Stiehler S; Sembill S; Schleicher O; Marx M; Rauh M; Krumbholz M; Karow A; Suttorp M; Woelfle J; Maj C; Metzler M
Haematologica; 2024 Aug; 109(8):2555-2563. PubMed ID: 38497150
[TBL] [Abstract] [Full Text] [Related]
[Next]
